BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3093433)

  • 1. Ahpatinins, new acid protease inhibitors containing 4-amino-3-hydroxy-5-phenylpentanoic acid.
    Omura S; Imamura N; Kawakita K; Mori Y; Yamazaki Y; Masuma R; Takahashi Y; Tanaka H; Huang LY; Woodruff HB
    J Antibiot (Tokyo); 1986 Aug; 39(8):1079-85. PubMed ID: 3093433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower homologues of ahpatinin, aspartic protease inhibitors, from a marine Streptomyces sp.
    Sun Y; Takada K; Nogi Y; Okada S; Matsunaga S
    J Nat Prod; 2014 Jul; 77(7):1749-52. PubMed ID: 24960234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of analogues of the carboxyl protease inhibitor pepstatin. Effects of structure on inhibition of pepsin and renin.
    Rich DH; Sun ET; Ulm E
    J Med Chem; 1980 Jan; 23(1):27-33. PubMed ID: 6767029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibition.
    Rich DH; Bernatowicz MS; Agarwal NS; Kawai M; Salituro FG; Schmidt PG
    Biochemistry; 1985 Jun; 24(13):3165-73. PubMed ID: 3927973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological activity of aspartic proteinase inhibitors related to pepstatin.
    Gunn JM; Owens RA; Liu WS; Glover GI
    Acta Biol Med Ger; 1981; 40(10-11):1547-53. PubMed ID: 6805191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and properties of a pepstatin-insensitive carboxyl proteinase from a gram-negative bacterium.
    Oda K; Sugitani M; Fukuhara K; Murao S
    Biochim Biophys Acta; 1987 Mar; 923(3):463-9. PubMed ID: 3548827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter: Hydroxypepstatin, a new peptatin produced by Streptomyces.
    Umezawa H; Miyano T; Murakami T; Takita T; Aoyagi T
    J Antibiot (Tokyo); 1973 Oct; 26(10):615-7. PubMed ID: 4599524
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of porcine pepsin by two substrate analogues containing statine. The effect of histidine at the P2 subsite on the inhibition of aspartic proteinases.
    Maibaum J; Rich DH
    J Med Chem; 1988 Mar; 31(3):625-9. PubMed ID: 3126296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: New pepstatins, pepstatins Bu, Pr and Ac produced by Streptomyces.
    Aoyagi T; Yagisawa Y; Kumagai M; Hamada M; Morishima H
    J Antibiot (Tokyo); 1973 Sep; 26(9):539-41. PubMed ID: 4600212
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis of the novel pi-(benzyloxymethyl)-protected histidine analogue of statine. Inhibition of penicillopepsin by pepstatin-derived peptides containing different statine side-chain derivatives.
    Maibaum J; Rich DH
    J Med Chem; 1989 Jul; 32(7):1571-6. PubMed ID: 2661819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pepstatin-derived inhibitors of aspartic proteinases. A close look at an apparent transition-state analogue inhibitor.
    Rich DH
    J Med Chem; 1985 Mar; 28(3):263-73. PubMed ID: 3882966
    [No Abstract]   [Full Text] [Related]  

  • 12. New pepstatins, pepstatins B and C, and pepstanone A, produced by streptomyces.
    Miyano T; Tomiyasu M; Iizuka H; Tomisaka S; Takita T
    J Antibiot (Tokyo); 1972 Aug; 25(8):489-91. PubMed ID: 4567545
    [No Abstract]   [Full Text] [Related]  

  • 13. Pepstatin inhibition mechanism.
    Marciniszyn J; Hartsuck JA; Tang J
    Adv Exp Med Biol; 1977; 95():199-210. PubMed ID: 339690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode of inhibition of acid proteases by pepstatin.
    Marciniszyn J; Hartsuck JA; Tang J
    J Biol Chem; 1976 Nov; 251(22):7088-94. PubMed ID: 993206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of all the stereoisomers of statine (4-amino-3-hydroxy-6-methylheptanoic acid). Inhibition of pepsin activity by N-carbobenzoxy-L-valyl-L-valyl-statine derived from the four stereoisomers.
    Liu WS; Smith SC; Glover GI
    J Med Chem; 1979 May; 22(5):577-9. PubMed ID: 379333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Candida albicans aspartyl protease inhibitor. II. A new pepstatin-ahpatinin group inhibitor, YF-044P-D.
    Sato T; Shibazaki M; Yamaguchi H; Abe K; Matsumoto H; Shimizu M
    J Antibiot (Tokyo); 1994 May; 47(5):588-90. PubMed ID: 8040057
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of oxygen nucleophiles in tetrahedral intermediates: 2H and 18O induced isotope shifts in 13C NMR spectra of pepsin-bound peptide ketone pseudosubstrates.
    Schmidt PG; Holladay MW; Salituro FG; Rich DH
    Biochem Biophys Res Commun; 1985 Jun; 129(2):597-602. PubMed ID: 3925948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases.
    Richards AD; Roberts R; Dunn BM; Graves MC; Kay J
    FEBS Lett; 1989 Apr; 247(1):113-7. PubMed ID: 2651157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of analogues of the carboxyl protease inhibitor pepstatin. Effect of structure in subsite P3 on inhibition of pepsin.
    Rich DH; Bernatowicz MS
    J Med Chem; 1982 Jul; 25(7):791-5. PubMed ID: 6809942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structures and activities of protease inhibitors of microbial origin.
    Umezawa H
    Methods Enzymol; 1976; 45():678-95. PubMed ID: 1012021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.